A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)

Thomas J. Herzog, Michael W. Sill, Joan L. Walker, David O'Malley, Mark Shahin, Koen Degeest, Sheldon A. Weiner, David Mutch, Robert L. Debernardo, Samuel S. Lentz

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)'. Together they form a unique fingerprint.

Medicine & Life Sciences